• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Establishment of an Inferred Reference Range for Blood Ammonia in Dogs and Cats Using a Point-of-Care Assay.使用即时检验法建立犬猫血氨推断参考范围
Vet Sci. 2025 Jun 17;12(6):596. doi: 10.3390/vetsci12060596.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

本文引用的文献

1
Hyperammonaemia: review of the pathophysiology, aetiology and investigation.高血氨症:病理生理学、病因学和检查的综述。
Pathology. 2024 Oct;56(6):763-772. doi: 10.1016/j.pathol.2024.06.002. Epub 2024 Jul 25.
2
Feline hyperammonemia associated with functional cobalamin deficiency: A case report.猫的高血氨症与功能性钴胺素缺乏相关:病例报告。
Can Vet J. 2023 May;64(5):426-430.
3
Current approaches to hepatic encephalopathy.当前肝性脑病的治疗方法。
Ann Hepatol. 2022 Nov-Dec;27(6):100757. doi: 10.1016/j.aohep.2022.100757. Epub 2022 Sep 14.
4
Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects.线粒体肝病:脂肪酸氧化缺陷和尿素循环缺陷管理中预期的困难。
World J Hepatol. 2022 Jan 27;14(1):180-194. doi: 10.4254/wjh.v14.i1.180.
5
Sex differences in renal ammonia metabolism.性别差异与肾脏氨代谢。
Am J Physiol Renal Physiol. 2021 Jan 1;320(1):F55-F60. doi: 10.1152/ajprenal.00531.2020. Epub 2020 Dec 14.
6
Hyperammonemia in azotemic cats.氮质血症猫的高血氨症。
J Feline Med Surg. 2021 Aug;23(8):700-707. doi: 10.1177/1098612X20972039. Epub 2020 Nov 20.
7
Transient hyperammonaemia following epileptic seizures in cats.猫癫痫发作后一过性高氨血症。
J Feline Med Surg. 2021 Jun;23(6):534-539. doi: 10.1177/1098612X20962747. Epub 2020 Oct 9.
8
Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs.减肥计划对肥胖犬生化和免疫指标、血清瘦素水平及心血管参数的影响
Front Vet Sci. 2020 Aug 6;7:398. doi: 10.3389/fvets.2020.00398. eCollection 2020.
9
Clinical manifestations and management of fatty acid oxidation disorders.脂肪酸氧化障碍的临床表现与治疗。
Rev Endocr Metab Disord. 2020 Dec;21(4):479-493. doi: 10.1007/s11154-020-09568-3.
10
Severe hyperammonemia from intense skeletal muscle activity: A rare case report and literature review.剧烈骨骼肌活动导致的严重高氨血症:一例罕见病例报告及文献综述
Medicine (Baltimore). 2019 Nov;98(47):e17981. doi: 10.1097/MD.0000000000017981.

使用即时检验法建立犬猫血氨推断参考范围

Establishment of an Inferred Reference Range for Blood Ammonia in Dogs and Cats Using a Point-of-Care Assay.

作者信息

Specchia Giulia, Seidel Emily Hannah Doran, Dye Charlotte

机构信息

Pride Veterinary Referrals, IVC Evidensia, Riverside Rd, Derby DE24 8HX, UK.

Creature Comforts Chiswick, 376 Chiswick High Rd., Chiswick, London W4 5TF, UK.

出版信息

Vet Sci. 2025 Jun 17;12(6):596. doi: 10.3390/vetsci12060596.

DOI:10.3390/vetsci12060596
PMID:40559833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197803/
Abstract

Point-of-care (POC) tests for blood ammonia (BA) measurement have not been well evaluated in veterinary species. This cross-sectional study sought to establish an inferred reference interval for BA using a POC analyser in dogs and cats. Blood ammonia was measured in 175 dogs and 63 cats for which relevant clinical history and laboratory data was available. Reference values were inferred based on comparisons between patients with and without disease pathologies reported to cause BA elevation. Descriptive statistics, Pearson Chi, and Mann-Whitney U testing were used to assess for associations between clinical parameters and BA concentration. Seventy-one percent (124/175) of dogs and forty-six percent (29/63) of cats had undetectable BA. Following the exclusion of dogs with potential causes of hyperammonaemia, all remaining dogs had BA < 30 µg/dL. With one exception, all dogs with BA > 30 µg/dL had liver disease. All dogs with a clinical suspicion of hepatic encephalopathy (HE) had BA > 40 µg/dL. Following the exclusion of cats with potential causes of hyperammonaemia, all remaining cats had BA < 25 µg/dL. Only 50% of cats with BA > 25 µg/dL had liver disease. All cats with a clinical suspicion of HE had BA > 30 µg/dL. Based on this study population, BA < 30 µg/dL and <25 µg/dL should be considered normal in dogs and cats, respectively. Additionally, dogs with BA > 30 µg/dL are likely to have liver disease, while cats with BA > 25 µg/dL appear to exhibit a wider variety of disease pathologies.

摘要

用于测量血氨(BA)的即时检验(POC)在兽医物种中尚未得到充分评估。这项横断面研究旨在使用POC分析仪为犬猫建立BA的推断参考区间。对175只犬和63只猫进行了血氨测量,并获取了相关临床病史和实验室数据。根据报告可导致BA升高的疾病病理状态的有无,对患者进行比较,从而推断参考值。使用描述性统计、Pearson卡方检验和Mann-Whitney U检验来评估临床参数与BA浓度之间的关联。71%(124/175)的犬和46%(29/63)的猫BA检测不到。排除有高氨血症潜在病因的犬后,所有剩余犬的BA均<30µg/dL。除一例例外,所有BA>30µg/dL的犬均患有肝病。所有临床怀疑患有肝性脑病(HE)的犬BA均>40µg/dL。排除有高氨血症潜在病因的猫后,所有剩余猫的BA均<25µg/dL。BA>25µg/dL的猫中只有50%患有肝病。所有临床怀疑患有HE的猫BA均>30µg/dL。基于该研究群体,犬和猫的BA分别<30µg/dL和<25µg/dL应被视为正常。此外,BA>30µg/dL的犬可能患有肝病,而BA>25µg/dL的猫似乎表现出更多样化的疾病病理状态。